Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Farydak( Panobinostat)帕比司他

Indications: Panobinostat is an HDAC inhibitor indicated for the treatment of patients already receiving bortezomib and immunomodulators. Histone deacetylase (HDAC) inhibitors are a group of drugs that can affect whether genes are active or turned on in cells

Share: